SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant market volatility as investors weigh strong earnings and massive cloud backlog growth against concerns regarding an aggressive forty billion dollar debt and equity financing plan for AI infrastructure. The community remains deeply divided, with bulls highlighting the record revenue and backlog as signs of a dominant AI gateway, while bears fixate on potential dilution and the intense capital expenditure cycle.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community debate the company's financial stability amid rising inflation data and continued geopolitical tensions involving Iran. Discourse remains highly polarized, with users clashing over the firm's strategic shifts, including the decision to scrap a planned media spin-off, while critics and supporters argue over the broader economic impact of current administration policies.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is currently facing significant selling pressure as investors weigh cooling inflation data against potential shifts in Fed policy and geopolitical uncertainty. The community is sharply divided between bulls viewing the current dip as a prime long-term buying opportunity and bears who believe the asset's recent performance signals a deeper, structural correction.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is experiencing a surge in trading activity and social media discussion following the company's new distribution agreement with NBCUniversal, which restores access to key channels after an eight-month blackout. The community is actively debating the stock's potential for a short squeeze due to high short interest and a limited float, though long-term investors remain divided over the company's history of dilution and management's past performance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as traders navigate a volatile pullback fueled by intensifying geopolitical tensions in Iran and uncertainty ahead of the high-profile SpaceX IPO. The community is actively debating whether this represents a healthy consolidation or the start of a deeper correction as market participants rotate capital and react to headline-driven volatility.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is experiencing extreme volatility as investors grapple with the severe decay of this 2x leveraged ETF following an indictment against Supermicro co-founders related to chip export violations. The community remains deeply divided, with some traders attempting to scalp the dip for quick profits while others warn that the fund's structure makes it a dangerous 'death trap' that could face further reverse splits or delisting risks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant downward pressure as investors rotate capital toward the highly anticipated SpaceX IPO, while market sentiment remains divided over the company's autonomous driving narrative and robotaxi scalability. The community is actively debating whether these factors represent a buying opportunity at key support levels or a deeper correction for a stock grappling with valuation concerns and competitive headwinds.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is seeing intense community debate as investors weigh the company's lack of a piloted transition flight against its strategic progress in infrastructure and defense partnerships. While some are accumulating shares ahead of potential regulatory catalysts and institutional backing, others are aggressively shorting the stock, citing management credibility concerns and the company's significant distance from commercial viability.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors react to a significant surge in prediction market volumes and positive momentum from institutional analysts highlighting the company's growth potential. While some community members remain skeptical regarding long-term price performance, many are actively discussing potential catalysts like the upcoming World Cup and the firm's expansion into new financial product offerings.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility driven by heavy short interest and concerns over the dilution necessary to fund aggressive M&A, though long-term investors are actively buying the dip to support the CEO's growth thesis. Community sentiment is deeply divided between those frustrated by recent price declines and those aggressively scaling positions in anticipation of a potential short squeeze and future margin expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the initiation of the blinded extension phase of the ALSTARS Trial (ClinicalTrials.gov Identifier: NCT07161999). Patients who...

Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces that the Company will present an overview of the ongoing ALSTARS trial...

Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative...

Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with...

Coya Therapeutics (COYA) Expected to Announce Earnings on Tuesday

Coya Therapeutics (NASDAQ:COYA) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Coya Therapeutics, Inc. (NASDAQ:COYA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation and five have issued a buy recomme...

Coya Therapeutics (NASDAQ:COYA) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised Coya Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

Coya Therapeutics' (COYA) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital reaffirmed a "buy" rating and set a $15.00 price target on shares of Coya Therapeutics in a research note on Friday...

Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a research...

Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.35	--	--	N/A
Q1 '26	-$0.42	-$0.32	23.02%	BEAT
Q4 '25	-$0.27	-$0.34	-24.76%	MISSED
Q3 '25	-$0.23	-$0.13	44.24%	BEAT
Q2 '25	-$0.42	-$0.36	14.01%	BEAT

COYACoya Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest COYA News